Skip to main content
27 February 2021
Last updated:
Friday 26 February 2021

User account menu

  • Log in
  • Register & Subscribe

Search this site:

 

Primary links

  • Home
  • News
  • About MedNous
  • Research Directory
  • Contact Us

Gene therapy

Purespring to develop gene therapies for the kidney

Saturday 13 February 2021
Interviewee/Contributor
Richard Francis
Organisation
Purespring Therapeutics Ltd
Gene therapy
Strategy
  • Read more about Purespring to develop gene therapies for the kidney

Integrated product development for ATMPs

Sunday 13 September 2020
Interviewee/Contributor
Claes Buxfeldt and Paula Salmikangas
Organisation
NDA Advisory Services Ltd
Gene therapy
Heath Technology Assessment (HTA)
Policy & Regulation
Regenerative medicine (Stem cells)
  • Read more about Integrated product development for ATMPs

A new paradigm for cancer therapy emerges

Sunday 26 July 2020
Interviewee/Contributor
Victoria English
Organisation
MedNous
Cancer (Oncology)
Clinical trials
Gene therapy
  • Read more about A new paradigm for cancer therapy emerges

The role of base and prime editing in therapeutics

Sunday 21 June 2020
Interviewee/Contributor
Jonathan Frampton
Organisation
Horizon Discovery Group Plc
Gene therapy
Regenerative medicine (Stem cells)
Strategy
  • Read more about The role of base and prime editing in therapeutics

Gene-edited therapies produce first clinical data

Sunday 21 June 2020
Interviewee/Contributor
Janet Lambert
Organisation
Alliance for Regenerative Medicine
Clinical trials
Gene therapy
Regenerative medicine (Stem cells)
  • Read more about Gene-edited therapies produce first clinical data

Gene and cell therapy as a new pillar of medicine

Sunday 21 June 2020
Interviewee/Contributor
Miguel Forte
Organisation
Bone Therapeutics SA
Commentary
Gene therapy
Regenerative medicine (Stem cells)
  • Read more about Gene and cell therapy as a new pillar of medicine

COVID-19's logistical impact on advanced therapies

Sunday 19 April 2020
Interviewee/Contributor
Matthew Lakelin
Organisation
TrakCel Ltd
Gene therapy
Strategy
  • Read more about COVID-19's logistical impact on advanced therapies

Solving the viral vector bottleneck during a pandemic

Sunday 19 April 2020
Interviewee/Contributor
Géraldine Guérin-Peyrou
Organisation
Polyplus-transfection SA
Gene therapy
Strategy
  • Read more about Solving the viral vector bottleneck during a pandemic

The changing landscape for haemophilia treatment

Saturday 22 February 2020
Interviewee/Contributor
Victoria English
Organisation
MedNous
Drug discovery
Gene therapy
  • Read more about The changing landscape for haemophilia treatment

Meeting the challenge of viral vector manufacture

Saturday 7 December 2019
Interviewee/Contributor
Gabriel Festoc
Organisation
Polyplus-Transfection SA
Gene therapy
Viral vector
  • Read more about Meeting the challenge of viral vector manufacture

Pagination

  • Page 1
  • Next page ››
Subscribe to Gene therapy

Select a News Category

  • Clinical Research
  • Company News
  • Finance, Grants, Deals
  • IPR & Legal
  • Regenerative Medicine
  • Regulation & Policy
  • Research & University News

Recent Appointments

Microbiotica expands management team
Wednesday February 10 2021
Philippe Dro joins Scenic Biotech as independent chairman
Wednesday February 10 2021
NOXXON announces senior appointment to its new advisory board
Wednesday February 10 2021
Wendy Levin joins Biofidelity as chief medical officer
Wednesday February 10 2021
VarmX appoints Gerard Short as chief medical officer
Wednesday February 10 2021

© 2021 Evernow Publishing Ltd. Powered by Drupal.